Analysis of Telavancin Activity Against a USA Collection of S. aureus Clinical Isolates Causing HAP (2013-2014)
Analysis of Telavancin Activity Against a USA Collection of S. aureus Clinical Isolates Causing HAP (2013-2014), Lead author: Mendes RE, presented at ID Week, October 7-11, 2015, San Diego, CA